NL8400430A - Nieuwe pinacidilpreparaten. - Google Patents

Nieuwe pinacidilpreparaten. Download PDF

Info

Publication number
NL8400430A
NL8400430A NL8400430A NL8400430A NL8400430A NL 8400430 A NL8400430 A NL 8400430A NL 8400430 A NL8400430 A NL 8400430A NL 8400430 A NL8400430 A NL 8400430A NL 8400430 A NL8400430 A NL 8400430A
Authority
NL
Netherlands
Prior art keywords
granules
pinacidil
preparation according
release
encapsulating material
Prior art date
Application number
NL8400430A
Other languages
English (en)
Dutch (nl)
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of NL8400430A publication Critical patent/NL8400430A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL8400430A 1983-02-11 1984-02-10 Nieuwe pinacidilpreparaten. NL8400430A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat
DK58983 1983-02-11

Publications (1)

Publication Number Publication Date
NL8400430A true NL8400430A (nl) 1984-09-03

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8400430A NL8400430A (nl) 1983-02-11 1984-02-10 Nieuwe pinacidilpreparaten.

Country Status (15)

Country Link
US (1) US4600577A (enExample)
JP (1) JPS59155312A (enExample)
BE (1) BE898882A (enExample)
DE (1) DE3404595A1 (enExample)
DK (1) DK58983D0 (enExample)
ES (1) ES8608490A1 (enExample)
FR (1) FR2540727B1 (enExample)
GB (1) GB2134785B (enExample)
IE (1) IE56604B1 (enExample)
IT (1) IT1196682B (enExample)
NL (1) NL8400430A (enExample)
NZ (1) NZ207010A (enExample)
PH (1) PH21734A (enExample)
SE (1) SE447871B (enExample)
ZA (1) ZA84856B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
DE3887591T2 (de) * 1987-07-07 1994-05-19 Beecham Group Plc Pinacidil zur Behandlung von pulmonaler Hypertonie oder Rechtsversagen.
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
AU764469B2 (en) 1999-01-29 2003-08-21 Disphar International B.V. Pharmaceutical compositions
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
SK287902B6 (sk) * 2001-01-31 2012-03-02 Evonik Rohm Gmbh Multiparticulate drug form and method for the preparation thereof
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
CN102014638A (zh) 2007-10-12 2011-04-13 武田制药北美公司 与食物摄入无关的治疗胃肠病症的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
NZ207010A (en) 1987-06-30
IE840146L (en) 1984-08-11
FR2540727A1 (fr) 1984-08-17
SE8400723L (sv) 1984-08-12
IE56604B1 (en) 1991-10-09
SE8400723D0 (sv) 1984-02-10
IT8467131A0 (it) 1984-02-13
SE447871B (sv) 1986-12-22
FR2540727B1 (fr) 1987-01-23
ZA84856B (en) 1984-09-26
GB8403572D0 (en) 1984-03-14
BE898882A (fr) 1984-08-10
US4600577A (en) 1986-07-15
DE3404595A1 (de) 1984-08-16
JPH0451528B2 (enExample) 1992-08-19
DE3404595C2 (enExample) 1993-04-29
IT1196682B (it) 1988-11-25
GB2134785B (en) 1986-07-02
ES8608490A1 (es) 1986-06-16
DK58983D0 (da) 1983-02-11
ES529660A0 (es) 1986-06-16
JPS59155312A (ja) 1984-09-04
PH21734A (en) 1988-02-10
GB2134785A (en) 1984-08-22
IT8467131A1 (it) 1985-08-13

Similar Documents

Publication Publication Date Title
AU2003246792B2 (en) Oral suspension of active principle microcapsules
RU2136283C1 (ru) Препарат с контролируемым высвобождением лекарства и способ его получения, способ лечения
EP0519870B1 (de) Neue orale Diclofenaczubereitung
EP3137060B2 (en) Extended release suspension compositions
US4772475A (en) Controlled-release multiple units pharmaceutical formulation
DE60020551T2 (de) Orale formulierung zur verabreichung in den ileum enthaltend einen hemmstoff des ileum-gallensäuretransports
AU781048B2 (en) Controlled release pellet formulation
EP0239361B1 (en) Sustained-release pharmaceutical preparation
ES2226886T3 (es) Forma de administracion de accion retardada que contiene sacarinato de tramadol.
US4857335A (en) Liquid controlled release formulations and method of producing same via multiple emulsion process
KR20050026518A (ko) 용해도가 낮은 활성 성분을 변형 방출시키는 경구 전달용마이크로캡슐
AU2003269067A1 (en) Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility
WO2003051343A1 (en) Pulsatile release histamine h2 antagonist dosage forms
JPS63287720A (ja) 医薬製材
EP3137057B1 (en) Extended release liquid compositions of metformin
US4600577A (en) Pharmaceutical preparations of pinacidal
EP0025686B1 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
US20180064663A1 (en) Extended release liquid compositions of metformin
KR20020015721A (ko) 키토산 분말 함유 고형 제제 및 그의 제조방법
EP3288539A1 (en) Extended release liquid compositions of metformin
EP0371683B1 (en) Controlled release flecainide acetate formulation
RU2447884C2 (ru) Фармацевтический состав с контролируемым высвобождением действующего вещества
JPH024575B2 (enExample)
EP4176874A1 (en) Pharmaceutical or nutraceutical composition with an alcohol resistant single layer coating system
Akhil et al. Formulation and evaluation of solid lipid multi particulate systems of Enalapril maleate

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable